North Carolina 2025-2026 Regular Session

North Carolina House Bill H750 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1		GENERAL ASSEMBLY OF NORTH CAROLINA
2	2		SESSION 2025
3		-	H 1
4		-	HOUSE BILL 750
	3	+	H D
	4	+	HOUSE BILL DRH10357-MGa-137
	5	+
5	6
6	7
7	8		Short Title: Community Health Center Grants for LARCs. (Public)
8		-	Sponsors: Representatives Johnson-Hostler and Clark (Primary Sponsors).
9		-	For a complete list of sponsors, refer to the North Carolina General Assembly web site.
10		-	Referred to: Appropriations, if favorable, Rules, Calendar, and Operations of the House
11		-	April 3, 2025
12		-	H750 -v-1
	9	+	Sponsors: Representative Johnson-Hostler.
	10	+	Referred to:
	11	+
	12	+	DRH10357 -MGa-137
13	13		A BILL TO BE ENTITLED 1
14	14		AN ACT APPROPRIATING FUNDS TO THE DEPARTMENT OF HEALTH AND HUMAN 2
15	15		SERVICES, DIVISION OF PUBLIC HEALTH, TO PROVIDE GRANTS TO NONPROFIT 3
16	16		COMMUNITY HEALTH CENTERS FOR THE PURCHASE AND DISTRIBUTION OF 4
17	17		LONG-ACTING REVERSIBLE CONTRACEPTIVES. 5
18	18		The General Assembly of North Carolina enacts: 6
19	19		SECTION 1. There is appropriated from the General Fund to the Department of 7
20	20		Health and Human Services, Division of Public Health, the sum of two million five hundred 8
21	21		thousand dollars ($2,500,000) in recurring funds for each year of the 2025-2027 fiscal biennium 9
22	22		to be used to award grants on a competitive basis to nonprofit community health centers. 10
23	23		Nonprofit community health centers selected to receive these grant funds shall use all such funds 11
24	24		to purchase and make available long-acting reversible contraceptives for underserved, uninsured, 12
25	25		or medically indigent patients. As used in this section, the term "long-acting reversible 13
26	26		contraceptives" means a contraceptive drug or device that meets all of the following criteria: 14
27	27		(1) Is a method of birth control that provides effective contraception for an 15
28	28		extended period of time without depending upon user action. 16
29	29		(2) Is designed as a temporary method of birth control that the user can elect to 17
30	30		discontinue. 18
31	31		(3) Has been approved by the United States Food and Drug Administration for 19
32	32		use as a contraceptive. 20
33	33		(4) Is obtained under a prescription written by a health care provider authorized 21
34	34		to prescribe medications under the laws of this State. 22
35	35		SECTION 2. This act becomes effective July 1, 2025. 23
	36	+	H.B. 750
	37	+	Apr 2, 2025
	38	+	HOUSE PRINCIPAL CLERK